Economic Modelling in Diabetes and Obesity


IHE has considerable experience in cutting edge research on the economics of obesity and diabetes, including more than 50 peer-reviewed publications and 60 podium and poster presentations.

IHE works with health authorities, life science companies, and academia on projects ranging from developing national treatment guidelines to estimating future disease burden and from early stage decision-making to market access.

IHE staff:

      • Have developed two internationally established and validated economic models of Type 2 diabetes, which have been accepted by HTA authorities in Sweden, Norway, U.K., Canada, Scotland, Ireland, and Australia
      • Have developed an economic micro-simulation model of Type 1 diabetes, which has been used for the Swedish Dental and Pharmaceutical Benefits Agency (TLV) for decision-making, among others
      • Have collaborated successfully with life science companies to obtain market access in European and North American countries
      • Have been commissioned by the National Board of Health and Welfare in Sweden to assist with development of diabetes treatment guidelines
      • Supervise doctoral students at Lund University and Karolinska Institute, perform peer review, and participate in diabetes-related advisory boards as health economics experts
      • Serve on the executive committee of biennial Mt. Hood Diabetes Modelling Challenge Network

Special areas of competence include

      • Economic modelling and market access support
      • Model development
      • Analysis of registry data and real-world evidence
      • Literature review
      • Patient preferences and Willingness-to-Pay


For more information, please contact: